Dangerous Counterfeit Drugs: A Growing Threat at the US-Mexico Border
Fake obesity drugs, particularly Ozempic and Mounjaro, are being sold in border areas between the US and Mexico, posing significant health risks. These counterfeit drugs contain incorrect dosages or harmful ingredients, potentially leading to severe health issues. WHO and FDA are raising alarms about this alarming trend.
- Country:
- India
Counterfeit obesity drugs are causing a heightened public health concern due to high prices and lack of insurance coverage, according to a report published in The Lancet. The report highlights an increase in the sale of fake Ozempic and Mounjaro in tourist areas in Mexico and at US border pharmacies.
Shabbir Safdar, from the Partnership for Safe Medicines, notes an unprecedented rise in fraud related to weight-loss injectables. These counterfeits often come with fake packaging, making it hard for consumers to distinguish between genuine and fake products. This issue is particularly prevalent in vacation areas in Mexico.
The World Health Organization and the US Food and Drug Administration have both raised concerns over these fraudulent sales. They warn of the dangerous consequences, such as incorrect dosages leading to potential life-threatening complications.
Google News